Overview
Majda Hadzihametovic, M.D., received her M.D. from University of Belgrade School of Medicine in 2006, followed by Postdoctoral Fellowship at the University of Pennsylvania, Scheie Eye Institute, from 2007 to 2012. After completing a year of General Surgery training at Drexel University College of Medicine in 2012, she completed Ophthalmology Residency at the same institution from 2013 to 2016, where she served as a chief resident during her final year. After finishing Medical Retina training at Duke, in 2017 she joined the faculty.
Dr. Hadziahmetovic’s is a clinician scientist with present research agenda focused on teleophthalmology. She is particularly interested in employing remote diagnosis in early diagnosis, suitable referral and timely treatment of diabetic retinopathy and age-related macular degeneration using cutting-edge noninvasive optic coherence tomography (OCT) imaging and fundus photography.
Dr. Hadziahmetovic also has a great interest in basic science, especially investigating new mouse models of retinal diseases. Her long term goal is better understanding of disease processes in Age related macular degeneration using different animal models and potential reversal of morphological changes.
Current Appointments & Affiliations
Recent Publications
Impact of glucagon-like peptide-1 receptor agonists on diabetic retinopathy: A meta-analysis of clinical studies emphasising retinal changes as a primary outcome.
Journal Article Clin Exp Ophthalmol · 2025 BACKGROUND: To determine if glucagon-like peptide-1 receptor agonists (GLP-1RA) are associated with the development and progression of diabetic retinopathy (DR). METHODS: A systematic search was conducted on PubMed, Cochrane Library, and Embase from incept ... Full text Link to item CiteClinical Outcomes of Therapeutic Interventions for Autoimmune Retinopathy: A Meta-analysis and Systematic Review.
Journal Article Ophthalmol Sci · 2025 TOPIC: Autoimmune retinopathy (AIR) is a group of rare inflammatory diseases treated with immunosuppression; however, there is no treatment consensus. This meta-analysis and review aims to investigate treatment effectiveness in slowing AIR progression. CLI ... Full text Link to item CiteEvaluating photodynamic therapy as an adjuvant treatment for neovascular AMD: A comprehensive meta-analysis.
Journal Article Asia Pac J Ophthalmol (Phila) · 2025 PURPOSE: This study aimed to assess the role of photodynamic therapy (PDT) as an adjunct to anti-vascular endothelial growth factor (Anti-VEGF) intravitreal injections in the treatment of neovascular age-related macular degeneration (nvAMD). METHODS: PubMe ... Full text Link to item CiteRecent Grants
A Phase 1/2 Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Clinical TrialPrincipal Investigator · Awarded by Ocugen, Inc. · 2024 - 2029Screening for Advanced Dry Age-Related Macular Degeneration in assisted living centers
Clinical TrialCo-Principal Investigator · Awarded by Apellis Pharmaceuticals, Inc · 2023 - 2028A Phase 2, Double-Masked, Placebo-Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Clinical TrialPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2022 - 2027View All Grants